Company Benitec Biopharma Limited Deutsche Boerse AG
Equities
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jerel Banks
CEO | Chief Executive Officer | 49 | 16-09-30 |
Peter Roelvink
CTO | Chief Tech/Sci/R&D Officer | - | 15-02-28 |
Megan Boston
CMP | Compliance Officer | 52 | 16-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
J. Buchi
BRD | Director/Board Member | 69 | 13-03-31 |
Edward Smith
BRD | Director/Board Member | 53 | 20-04-13 |
Peter Francis
BRD | Director/Board Member | 68 | 06-01-31 |
Jerel Banks
CEO | Chief Executive Officer | 49 | 16-09-30 |
Megan Boston
CMP | Compliance Officer | 52 | 16-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,367,485 | 8,497,929 ( 90.72 %) | 0 | 90.72 % |
Company contact information
![address Benitec Biopharma Limited](https://cdn.zonebourse.com/static/address/453260.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+25.83% | 47.96B | |
+45.77% | 41.47B | |
+0.69% | 42.45B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |